Explore the latest HER2-targeted therapies for non-small cell lung cancer, including treatment options and patient-centered decision-making strategies. In this episode, the panel provides an in-depth ...
Recently published Non-small Cell Lung Cancer Market Insights report includes a comprehensive understanding of current ...
The National Institute for Health and Care Excellence (NICE) has recommended encorafenib plus binimetinib for the treatment of adults with advanced non-small-cell lung cancer (NSCLC) that has a ...
The MarketWatch News Department was not involved in the creation of this content. This press release is not intended for UK media -- HERNEXEOS(R) (zongertinib tablets) approved based on an objective ...
Dr. Priya Hays discusses the mechanisms of treatment resistance in cancer, highlighting their significance for developing ...
This study evaluates inclusion of National Comprehensive Cancer Network (NCCN) guideline recommended biomarkers for metastatic non–small cell lung cancer (NSCLC) in commercially available targeted ...
The Business Research Company's Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Non-Small Cell Lung Cancer (NSCLC) Global Market ...
Part C domestic enrollment is underway at three clinical sites in the U.S. CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA ...
The non-small cell lung cancer market is experiencing robust growth, driven by the increasing incidence of lung cancer and continuous advancements in precision medicine. The introduction of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results